Chromosome 17 abnormalities and mutation of the TP53 gene: correlation between cytogenetics, flow cytometry and molecular analysis in three cases of chronic myeloid leukemia
AUTOR(ES)
Otero, Luize, Cavalcanti Júnior, Geraldo Barroso, Klumb, Claudete Esteves, Scheiner, Marcos Antonio Mauricio, Magluta, Eliane Pereira Simões, Fernandez, Teresa de Souza, Silva, Maria Luiza Macedo, Pires, Virgínia, Andrade, Gabriela Vasconcelos, Maia, Raquel Ciuvalschi, Tabak, Daniel
FONTE
Genetics and Molecular Biology
DATA DE PUBLICAÇÃO
2005-03
RESUMO
chronic myeloid leukemia (CML) have been described. This chromosomal region contains the tumor suppressor gene TP53 that may be an important factor in the evolution of this disease. In this study, we used flow cytometry and western blotting to assess p53 protein expression and single stranded conformational polymorphism to examine TP53 gene alterations in three patients with CML who showed alterations in 17p. Only the case with del(17)(p11) had p53 expression positive by flow cytometry and an abnormal migration pattern by SSCP analysis. The importance of the correlation between the results obtained with these techniques, as well as the clinical course of the patients, are discussed.
Documentos Relacionados
- Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods
- Codon 72 polymorphism of the TP53 gene
- Polimorfismos do gene TP53 no linfoma de Hodgkin
- Mutação pontual do códon 249 do TP53 no carcinoma hepatocelular
- The TP53 fertility network